• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Modern Approaches To The Selection Of Protected Cephalosporins Iii For Therapy Of Community-Acquired Pneumonia In Children

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Modern Approaches To The Selection Of Protected Cephalosporins Iii For Therapy Of Community-Acquired Pneumonia In Children

    Authors

    • Mukhlisakhon Ravshanhanovna Kurbanova
    • Furkat Mukhitdinovach Shamsiev
    • Rano Anvarbekovna Musajavova

    Republican Specialized Scientific and Practical Medical Center of Pediatrics of the Ministry of Health of the Republic of Uzbekistan, Tashkent

,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

The aim of the study was to study the effectiveness of the use of protected cephalosporin III generation Extum in the treatment of community-acquired pneumonia in children. The study included 100 children with community-acquired pneumonia at the age from 1 to 15 years, who were observed and treated in the department of pulmonology. In the process of complex clinical and laboratory examination of children, biochemical, microbiological and immunological research methods were used. Microbiological studies have shown that in children with community-acquired pneumonia, S. Pneumonia occupies a significant place in the etiological structure and accounts for 42.0% of cases, a high sensitivity of pneumococcus to injectable cephalosporin of the third generation has been established. When included in complex treatment, protected cephalosporin of the third generation Extum leads to a decrease in the frequency of repeated acute respiratory infections and their complications by 2.2 times, the frequency of recurrent bronchitis and pneumonia by 1.7 times, which indicates a high therapeutic effectiveness of the proposed treatment

Keywords

  • Pediatrics
  • Pneumonia
  • cephalosporin
  • community-acquired pneumonia
  • XML
  • PDF 237.89 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 305
    • PDF Download: 298
European Journal of Molecular & Clinical Medicine
Volume 7, Issue 3
November 2020
Page 3008-3014
Files
  • XML
  • PDF 237.89 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 305
  • PDF Download: 298

APA

Kurbanova, M. R., Shamsiev, F. M., & Musajavova, R. A. (2020). Modern Approaches To The Selection Of Protected Cephalosporins Iii For Therapy Of Community-Acquired Pneumonia In Children. European Journal of Molecular & Clinical Medicine, 7(3), 3008-3014.

MLA

Mukhlisakhon Ravshanhanovna Kurbanova; Furkat Mukhitdinovach Shamsiev; Rano Anvarbekovna Musajavova. "Modern Approaches To The Selection Of Protected Cephalosporins Iii For Therapy Of Community-Acquired Pneumonia In Children". European Journal of Molecular & Clinical Medicine, 7, 3, 2020, 3008-3014.

HARVARD

Kurbanova, M. R., Shamsiev, F. M., Musajavova, R. A. (2020). 'Modern Approaches To The Selection Of Protected Cephalosporins Iii For Therapy Of Community-Acquired Pneumonia In Children', European Journal of Molecular & Clinical Medicine, 7(3), pp. 3008-3014.

VANCOUVER

Kurbanova, M. R., Shamsiev, F. M., Musajavova, R. A. Modern Approaches To The Selection Of Protected Cephalosporins Iii For Therapy Of Community-Acquired Pneumonia In Children. European Journal of Molecular & Clinical Medicine, 2020; 7(3): 3008-3014.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus